CYTOPHAGE TECHNOLOGIES LTD (CYTO.CA) Stock Earnings & Estimates
Canada - TSX Venture Exchange - TSX-V:CYTO - CA2328211081 - Common Stock
0.165 CAD
+0.01 (+3.13%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | ||
|---|---|---|---|---|---|
| Revenue YoY % growth | |||||
| EBITDA YoY % growth | -2.909M | -3.298M -13.37% | -4.526M -37.26% | -4.467M 1.31% | |
| EBIT YoY % growth | -3.205M | -3.662M -14.28% | -5.039M -37.60% | -5.174M -2.68% | |
| Operating Margin | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A |
All data in CAD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in CAD
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |